# RELMADA THERAPEUTICS INC (RLMD)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/RLMD/

- Reporting holders: 2
- Reported value: $2.3K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $2.0K | 533 | 0.0% | 2 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $260 | 69 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 2 | $2.3K |
| Q2 2026 | 130 | $733.2M |
| Q1 2026 | 106 | $600.9M |
| Q4 2025 | 80 | $251.9M |
| Q3 2025 | 45 | $15.8M |
| Q2 2025 | 49 | $3.2M |
| Q1 2025 | 44 | $1.7M |
| Q4 2024 | 52 | $4.8M |
| Q3 2024 | 71 | $43.7M |
| Q2 2024 | 80 | $42.8M |
| Q1 2024 | 92 | $70.2M |
| Q4 2023 | 83 | $58.5M |